Response to Re: 'Neoadjuvant chemotherapy for advanced ovarian cancer. Who really benefits?'

Aust N Z J Obstet Gynaecol. 2018 Dec;58(6):E26-E27. doi: 10.1111/ajo.12925.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Ovarian Epithelial*
  • Chemotherapy, Adjuvant
  • Cytoreduction Surgical Procedures
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Ovarian Neoplasms*